Drug Topics

MAY 29, 2025

The data show a decrease in all-cause mortality for sustained midlife weight loss achieved without surgical or pharmacological interventions.

315

315

STAT

MAY 29, 2025

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.  Sign up here  to receive it in your inbox on Tuesdays and Thursdays. NIH is terminating research grants left and right, impeding early career paths and leading some young scientists to consider becoming plumbers.

Vaccines 121

Vaccines 121

Drug Topics

MAY 29, 2025

The replacement therapy is indicated for patients 5 years and older, marking the first approval for an oral solution form of hydrocortisone.

FDA 315

FDA 315

STAT

MAY 29, 2025

For the past decade, Stealth BioTherapeutics has ridden a rollercoaster trying to convince the Food and Drug Administration to approve its ultra-rare disease drug. Now, the company has encountered yet another twist — an unexpected regulatory rejection that will not only delay access and strain its finances, but ensure some of the most vulnerable patients are denied the treatment.

FDA 95

FDA 95

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

MAY 29, 2025

Alecia Lashier, chief automation officer and executive vice president at iA, discusses transformations in the pharmacy industry and how theyve impacted pharmacists and their businesses.

247

247

STAT

MAY 29, 2025

Radiologists interpret more than 40 million mammograms in the United States every year. In 2025, AI tools to help detect or diagnose possible cancer will be applied to millions of them.  As the Food and Drug Administration has cleared several AI algorithms to analyze mammograms, some imaging centers are adopting them en masse. RadNet, which owns more than 400 U.S. radiology practices, says it deploys its own AI algorithm in 600,000 mammograms every year.

133

133

STAT

MAY 29, 2025

Misinformation spreads faster than prairie fire, often with as much destruction. Right now, state legislatures nationwide are debating bills based on erroneous beliefs that would strip away public health protections. Calls to increase vaccine exemptions in schools and daycare centers, for example, have contributed to measles outbreaks in Texas and elsewhere.

Vaccines 128

Vaccines 128

Pharmaceutical Technology

MAY 29, 2025

The HSS has terminated a contract previously awarded to Moderna to help advance a vaccine candidate targeting bird flu.

Vaccines 111

Vaccines 111

European Pharmaceutical Review

MAY 29, 2025

Research has illustrated a potential new device for harvesting T cells that could improve the cost-effectiveness of manufacturing CAR T-cell therapy and make the cancer immunotherapy more accessible to patients. In development by investigators in the US, the device, called capture and glow (CAPGLO), captures T cells via a magnetic field and makes them visible using glowing fluorescent tags.

98

98

Pharmafile

MAY 29, 2025

Global non-profit organisation, DEBRA Research, and clinical dermatology company, Dermaliq Therapeutics, have announced a collaboration to advance drug development for those affected by epidermolysis bullosa (EB). EB is a group of rare, genetic skin disorders with no known cure, meaning new treatments are a highly pressing medical need. The partners will initially focus on improving […] The post DEBRA Research and Dermaliq Therapeutics collaborate to advance treatment for rare skin disorde

59

59

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Marketing Network

MAY 29, 2025

AI is rapidly transforming the digital marketing landscape, and nowhere is this more evident than in the evolution of search behavior. With tools like ChatGPT, Bing Copilot, and Googles AI Overviews influencing how users discover and engage with content, pharma marketers are being challenged to rethink traditional metrics. So how can you actually track inbound AI search traffic?

52

52

pharmaphorum

MAY 29, 2025

Eisai has won a lawsuit blocking FDA approval of Shilpa's generic of cancer blockbuster Lenvima until 2036, although the verdict could go to appeal

FDA 85

FDA 85

Pharmacy Times

MAY 29, 2025

Elranatamab shows promising efficacy and manageable safety in transplant-ineligible newly diagnosed multiple myeloma patients, highlighting its potential as a treatment option.

73

73

Fierce Healthcare

MAY 29, 2025

Electronic health record giant Epic rolled out a new initiative to propel the adoption of generative AI tools among healthcare organizations.

71

71

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

MAY 29, 2025

The investigators suggest that early detection and treatment of chronic kidney disease (CKD) in childhood cancer survivors may decrease late complications and mortality.

65

65

pharmaphorum

MAY 29, 2025

GSK has said it will file its oral carbapenem antibiotic tebipenem HBr for approval before the end of this year as a treatment for complicated UTIs

64

64

Pharmacy Times

MAY 29, 2025

Corrine Stahura, PharmD, and Sophia Gilardone, PharmD, BCOP, discuss recent clinical trial data and evolving guideline recommendations for HER2- and HER3-directed antibody-drug conjugates (ADCs) in nonsmall cell lung cancer (NSCLC), highlighting differences in efficacy, safety, and patient selection criteria.

65

65

Fierce Healthcare

MAY 29, 2025

Retail giant Walmart is rolling out a new platform for insurers and benefit managers that's designed to make it easier to encourage healthy eating.

Insurance 72

Insurance 72

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

MAY 29, 2025

Epcoritamab shows impressive long-term remission rates in relapsed large B-cell lymphoma, highlighting its potential as a key treatment option.

65

65

pharmaphorum

MAY 29, 2025

HHS cancels funding for Moderna's pandemic flu vaccine development in a move viewed by some as an attack on mRNA technology

Vaccines 55

Vaccines 55

Pharmacy Times

MAY 29, 2025

V114, a 15-valent pneumococcal conjugate vaccine (PCV), provided better protection against serotypes 22F and 33F compared with 13-valent PCV (PCV13).

Vaccines 65

Vaccines 65

Pharmafile

MAY 29, 2025

Ryvu Therapeutics has promoted Justyna tek, chief people officer, to its management board. The appointment reflects the companys focus on organisational development as it continues to advance a pipeline of oncology programmes. tek joined Ryvu in 2021, leading the creation of its human resources (HR) function during a period of operational growth. Since then, she […] The post Ryvu Therapeutics appoints Justyna tek to management board appeared first on Pharmafile.

64

64

Pharmaceutical Technology

MAY 29, 2025

iTeos will look to distribute its cash reserves to shareholders, along with proceeds raised from selling pipeline assets.

52

52

Fierce Healthcare

MAY 29, 2025

Talkspace's partnership with Amazon Pharmacy marks the first virtual behavioral health provider to integrate with the online pharmacy for medication fulfillment and rapid home delivery to consumers.

53

53

Pharma Marketing Network

MAY 29, 2025

Living with Crohn’s disease can feel like navigating an unpredictable path, especially when it comes to food. While there is no one-size-fits-all diet, understanding the principles of a healthy Crohn’s disease diet can empower you to manage symptoms and enhance your quality of life. So, what can you eat without triggering a flare-up? Table of Contents Understanding Crohn’s Disease and Nutrition Safe Food Choices During Remission What to Eat During a Flare-Up Special Diets and S

Documentation 52

Documentation 52

Fierce Healthcare

MAY 29, 2025

Dreem Health, a sleep platform now offered to members with major insurers including Humana, is hoping to revolutionize the quality of sleep nationwide.

Insurance 53

Insurance 53

Pharmaceutical Commerce

MAY 29, 2025

The designation allows pharmacists to substitute it for Humira without prescriber approval (per state law), which expands patient access in the process.

FDA 52

FDA 52

Pharmaceutical Technology

MAY 29, 2025

Expanding the reach of CAR-T therapeutics could unlock promising new treatment possibilities for solid tumour patients.

52

52

pharmaphorum

MAY 29, 2025

Join us at Axtria Ignite 2025 on 4th to 5th June to explore and lead in the agentic era. Learn from industry experts and leaders shaping the future of business.

69

69

Pharmaceutical Technology

MAY 29, 2025

Drug pricing and reimbursement constraints are a major concern for the pharmaceutical industry. In order to balance generating revenues with ensuring that a new medicine reaches the largest possible group of patients, companies must consider price and reimbursement across multiple countries, act early in the development cycle and ensure the evidence required to support their commercial strategy is built into their development plans.

52

52

Fierce Healthcare

MAY 29, 2025

A pair of letters to providers, risk managers, state medical boards and specific hospitals is the latest in a pressure campaign against gender-affirming care services.

Hospitals 45

Hospitals 45

Pharmaceutical Technology

MAY 29, 2025

Telesis Bio has announced a licensing agreement with Regeneron, enabling the latter to deploy the Gibson SOLA platform at R&D facilities.

52

52

pharmaphorum

MAY 29, 2025

MSD and Daiichi Sankyo suffer another setback with their HER3 programme ahead of a crucial data readout at ASCO.

FDA 45

FDA 45